Factors that Affect the Adherence to ADHD Medications during a Treatment Continuation Period in Children and Adolescents: A Nationwide Retrospective Cohort Study Using Korean Health Insurance Data from 2007 to 2011
1
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Objective: Several factors, such as male gender, older age, type of insurance, comorbid conditions, and medication type, have been associated with attention-deficit/hyperactivity disorder (ADHD) medication adherence rates, but the results have been inconsistent. We analyzed data to answer several questions: 1) How old were patients who first refilled their treatment medications used primarily for ADHD, regardless of the medication type? 2) What socio-demographic factors are associated with medication adherence? 3) What medical conditions, such as medication type and comorbid diagnosis, influence adherence? Methods: We analyzed National Health Insurance data, which comprised continuously enrolled Korean National Medical Insurance children (6–18 years) with at least 2 ADHD prescription claims (January 2008–December 2011). The persistence of use regarding the days of continuous therapy without a 30-day gap were measured continuously and dichotomously. Adherence, using a medication possession ratio (MPR), was measured dichotomously (80% cut-off). Results: The cumulative incidence of index cases that initiated medication refills for ADHD treatment during the 4 year period was 0.85%. The patients who exhibited a MPR greater than 80 comprised approximately 66%. The medication type, high school age groups, physician speciality, treatment at a private clinic, and comorbid conditions were associated with medication adherence during continuous treatment using a multivariate analysis. Conclusion: A better understanding of ADHD treatment patterns may lead to initiatives targeted at the improvement of treatment adherence and persistence. Other factors, including the severity, family history, costs, type of comorbidities, and switching patterns, will be analyzed in future studies.
Abstract
Objective: Several factors, such as male gender, older age, type of insurance, comorbid conditions, and medication type, have been associated with attention-deficit/hyperactivity disorder (ADHD) medication adherence rates, but the results have been inconsistent. We analyzed data to answer several questions: 1) How old were patients who first refilled their treatment medications used primarily for ADHD, regardless of the medication type? 2) What socio-demographic factors are associated with medication adherence? 3) What medical conditions, such as medication type and comorbid diagnosis, influence adherence? Methods: We analyzed National Health Insurance data, which comprised continuously enrolled Korean National Medical Insurance children (6–18 years) with at least 2 ADHD prescription claims (January 2008–December 2011). The persistence of use regarding the days of continuous therapy without a 30-day gap were measured continuously and dichotomously. Adherence, using a medication possession ratio (MPR), was measured dichotomously (80% cut-off). Results: The cumulative incidence of index cases that initiated medication refills for ADHD treatment during the 4 year period was 0.85%. The patients who exhibited a MPR greater than 80 comprised approximately 66%. The medication type, high school age groups, physician speciality, treatment at a private clinic, and comorbid conditions were associated with medication adherence during continuous treatment using a multivariate analysis. Conclusion: A better understanding of ADHD treatment patterns may lead to initiatives targeted at the improvement of treatment adherence and persistence. Other factors, including the severity, family history, costs, type of comorbidities, and switching patterns, will be analyzed in future studies.
참고문헌 (38)
- Gajria K, "Adherence, persistence, and medication discontinuation in patients with attentiondeficit", hyperactivity disorder - a systematic literature review, 2014, pp.10, 1543~1569
- Barkley RA, "Young adult outcome of hyperactive children : adaptive functioning in major life activities", J Am Acad Child Adolesc Psychiatry, 45, pp.192~202 (2006)
- Biederman J, "New insights into the comorbidity between ADHD and major depression in adolescent and young adult females", J Am Acad Child Adolesc Psychiatry, 47, pp.426~434 (2008)
- Reimer B, "The impact of distractions on young adult drivers with attention deficit hyperactivity disorder(ADHD)", Accid Anal Prev, 42, pp.842~851 (2010)
- Gupta R, "Problem gambling in adolescents : an examination of the pathways model", J Gambl Stud, 29, pp.575~588 (2013)
- Biederman J, "Are girls with ADHD at risk for eating disorders? Results from a controlled, five-year prospective study", J Dev Behav Pediatr, 28, pp.302~307 (2007)
- Thiruchelvam D, "Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD", J Am Acad Child Adolesc Psychiatry, 40, pp.922~928 (2001)
- Barbaresi WJ, "Modifiers of long-term school outcomes for children with attention-deficit", hyperactivity disorder : does treatment with stimulant medication make a difference? Results from a population-based study, 2007, pp.28, 274~287
- Wilens TE, "Effect of prior stimulant treatment for attentiondeficit", hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents, 2008, pp.162, 916~921
- Biederman J, "Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study", Pediatrics, 124, pp.71~78 (2009)
- Charach A, "Improving psychostimulant adherence in children with ADHD", Expert Rev Neurother, 8, pp.1563~1571 (2008)
- Murray DW, "A clinical review of outcomes of the multimodal treatment study of children with attention-deficit", hyperactivity disorder(MTA), 2008, pp.10, 424~431
- Barner JC, "ADHD medication use, adherence, persistence and cost among Texas Medicaid children", Curr Med Res Opin, 27(Suppl 2), pp.13~22 (2011)
- Charach A, "Enhancing ADHD medication adherence : challenges and opportunities", Curr Psychiatry Rep, 15, pp.371~ (2013)
- Perwien A, "Stimulant treatment patterns and compliance in children and adults with newly treated attention-deficit", hyperactivity disorder, 2004, pp.10, 122~129
- Lachaine J, "Treatment patterns, adherence, and persistence in ADHD: a Canadian perspective", Postgrad Med, 124, pp.139~148 (2012)
- McCarthy S, "Persistence of pharmacological treatment into adulthood, in UK primary care, for ADHD patients who started treatment in childhood or adolescence", BMC Psychiatry, 12, pp.219~ (2012)
- Pottegard A, "The use of medication against attention deficit hyperactivity disorder in Denmark : a drug use study from a national perspective", Eur J Clin Pharmacol, 68, pp.1443~1450 (2012)
- Pottegard A, "The use of medication against attention deficit", hyperactivity disorder in Denmark : a drug use study from a patient perspective, 2013, pp.69, 589~598
- The Operation of Nationwide Health Insurance and its Implications, "Kim JS", Korea Development Institute (KDI) School of Public Policy and Management, ~ (2012)
- National Helath Insurance Service, "National Health Insurance Statistical Yearbook 2014", National Health Insurance Service, ~ (2014)
- National Health Insurance Service, "National Health Insurance Statistical Yearbook 2011", National Health Insurance Service, ~ (2011)
- Hong M, "Nationwide rate of attention-deficit hyperactivity disorder diagnosis and pharmacotherapy in Korea in 2008-2011", Asia Pac Psychiatry, 6, pp.379~385 (2014)
- Polanczyk G, "The worldwide prevalence of ADHD : a systematic review and metaregression analysis", Am J Psychiatry, 164, pp.942~948 (2007)
- Zuvekas SH, "Recent trends in stimulant medication use among U.S. children", Am J Psychiatry, 163, pp.579~585 (2006)
- Kraut AA, "Comorbidities in ADHD children treated with methylphenidate : a database study", BMC Psychiatry, 13, pp.11~ (2013)
- Hodgkins P, "Management of ADHD in children across Europe: patient demographics, physician characteristics and treatment patterns", Eur J Pediatr, 172, pp.895~906 (2013)
- Hudson JL, "Explaining racial and ethnic differences in children’s use of stimulant medications", Med Care, 45, pp.1068~1075 (2007)
- Ki M, "Delays in depression treatment among Korean population", Asia Pac Psychiatry, 6, pp.414~424 (2014)
- Hodgkins P, "Pharmacologic treatment of attention-deficit", hyperactivity disorder in children: incidence, prevalence, and treatment patterns in the Netherlands, 2011, pp.33, 188~203
- Christensen L, "Pharmacological treatment patterns among patients with attention-deficit", hyperactivity disorder : retrospective claims-based analysis of a managed care population, 2010, pp.26, 977~989
- Sikirica V, "Immediate-release versus extended-release guanfacine for treatment of attention-deficit", hyperactivity disorder, 2013, pp.5, e85~e94
- Lawson KA, "Utilization patterns of stimulants in ADHD in the Medicaid population: a retrospective analysis of data from the Texas Medicaid program", Clin Ther, 34, pp.944~956 (2012)
- Gau SS, "Determinants of adherence to methylphenidate and the impact of poor adherence on maternal and family measures", J Child Adolesc Psychopharmacol, 16, pp.286~297 (2006)
- Gau SS, "National survey of adherence, efficacy, and side effects of methylphenidate in children with attention-deficit", hyperactivity disorder in Taiwan, 2008, pp.69, 131~140
- Atzori P, "Predictive factors for persistent use and compliance of immediate-release methylphenidate : a 36-month naturalistic study", J Child Adolesc Psychopharmacol, 19, pp.673~681 (2009)
- "Pressure to study on children here greater than anywhere else"[URL]
- 유창훈, "외래 의료 이용에서 종별 의료기관 선택에 영향을 미치는 요인", 대한의사협회지, 55(9), pp.898~910 (2012), 대한의사협회